
|Articles|February 15, 2004
Wavefront-guided LASIK yields positive results for hyperopia, astigmatism
Anaheim, CA-Wavefront-guided CustomCornea LASIK (Alcon) is yielding favorable early results in the ongoing FDA clinical trial evaluating its efficacy and safety for the treatment of hyperopia, hyperopic astigmatism, and mixed astigmatism, according to Omar J. Hakim, MD, FRCSC.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
4
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
5

















































.png)


